Session 994: Gene Therapy, Part 1

Cochair(s): C Baum, S Ikehara
Date: Sat 9 February 2002, Time: 14:00 - 16:00
Location: CIS Auditorium

Oral Presentations

Time Number Title / Authors / Affiliations
14:00 502 Horizontal gene transfer: implications for tumor progression.
L Holmgren
Karolinska Institute, Stockholm, Sweden Sweden
14:15 503 Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells
Y Ge, Z Chen, JX Kang
Massachusetts General Hospital/Harvard Medical School, Charlestown, MA
14:30 504 Identification of oncogenes by proviral tagging in mouse cancer models I: Sint1, a proto-oncogene belonging to the septin gene family
AB Sorensen, S Warming, EM Füchtbauer, FS Pedersen
1Department of Molecular and Structural Biology, and Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus C, Denmark, 2Department of Molecular and Structural Biology, University of Aarhus, Aarhus, Denmark
14:45 505 Adenovirus mediated intratumoral E2F-1 gene therapy against leiomyosarcoma in vitro and in vivo
SA Vorburger, N Hetrakul, M Wilson-Heiner, D Yu, RE Pollock, B Feig, P Pisters, KK Hunt
Department of Surgical Oncology, University of Texas, M.D. Anderson Cancer Center, Houston, Tx United States
15:00 506 Gene quantification using multiplex real-time pcr: advantages and limitations
D Klein
University of Veterinary Sciences, Vienna, Austria
15:15 507 *The role of PTEN gene therapy in bladder cancer
HB Grossman, M Tanaka
The University of Texas M. D. Anderson Cancer Center, Houston, TX
15:30 508 Atlas of genetics and cytogenetics in oncology and haematology.
JL Huret, P Dessen, A Bernheim
1Department of Medical Information, University Hospital, Poitiers, France, 2Genetics and Oncology Villejuif, France

Poster Presentations

Number Title / Authors / Affiliations
509 Application of novel tumor suppressor gene "ines" in nonviral gene delivery for cancer gene therapy
H Yanagie, H Sugiyama, Y Furuya, Y Nonaka, Y Takeda, I Yoshizaki, S Naka, H Shinnkawa, A Nojiri, H Niwa, K Ariki, H Yasuhara, M Eriguchi, B Lee, S Li, L Huang, K Maruyama
Teikyo University School of Medicine, Ichihara Hospital, Ichihara, Chiba Japan
510 Application of jts-1 fusogenic peptide to enhancement of transfection efficiency in nonviral vector delivery for cancer gene therapy
H Yanagie, K Maruyama, H Sugiyama, M Eriguchi, Y Nonaka, Y Takeda, I Yoshizaki, Y Furuya, H Yasuhara, B Lee, S Li, L Huang
1Teikyo niversity, School of Medicine Ichihara Hospital, Chiba, Japan, 2School of Pharmacy, Kanagawa, Japan, 3Nihon Medical University, Tokyo, Japan, 4Institute of Medical Science, University of Tokyo, Tokyo, Japan, 5School of Pharmacy, University of Pittsburgh, Pittsburgh, USA
511 Enhancement of transfection efficiency by jts-1 fusogenic peptide in gastric cancer
Y Furuya, H Yanagie, S Okuda, M Iwasaki, S Naka, T Nojiri, H Shinkawa, K Ariki, H Niwa, B Lee, S Li, L Huang, M Eriguchi, H Yasuhara, K Maruyama
1Teikyo University, Chiba, Japan, 2School of Pharmacy, Kanagawa, Japan, 3School of Pharmacy, University of Pittsburgh, Pittsburgh, USA, 4Institute of Medical Science, University of Tokyo, Tokyo, Japan
512 *Restoration of an impaired TGF-beta1 autocrine growth-inhibitory circuit using a gene transfer approach results in growth inhibition of some epithelial cancer cell lines.
Z Zeinoun, E Teugels, J Vermeij, B Neyns, J De Greve
AZ-VUB, Brussels, Brabant, Belgium
513 Gene Transfer into solid tumors - is a special application device beneficial ?
U Liebers, H Kuhn, B Schmidt, G Wolff, C Witt
1Dept. of Pulmology, Medical School, Germany, Germany, 2of the Humboldt University Berlin, Germany, Germany, 3Dept. of Pulmology, Medical Clinic, Germany
514 Contribution of a combination of scopadulciol and acyclovir/ganciclovir to the antitumor efficacy in HSV-TK gene therapy system
K Hayashi, T Hayashi
Toyama Medical and Pharmaceutical University, Toyama, Japan
515 Cyclooxygenase-2 inducing mcl-1-dependent survival mechanism in human lung adenocarcinoma cl1.0 cells: involvement of pi 3-k/akt pathway
National Taiwan University College of Medicine, Taipei, none Taiwan
516 Modified OPPA/COPP chemotherapy for the treatment of Hodgkin disease in Turkish children
S Gözdasoglu, E Üna, M Ertem, G Yavuz, A Pamir, N Taçyildiz, Y Genç, AO Çavdar
1Divisions of Pediatric Hematology and Oncology, Department of Pediatrics School of Medicine, Ankara University, , 2Cancer Committee, Turkish Academy of Sciences and Pediatric Hematology-Oncology Research Centre Ankara University Ankara - Turkey
517 Predictive value of quantitative DNA-analysis for patients with cholangiocellular carcinoma
H Al-Abadi, S Jonas, T Steinmueller, I Rotter, P Neuhaus
Department of Surgery, Charite, Campus Virchow Klinikum, Humboldt University of Berlin
518 Interfeton alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C
S Maruyama, T Suou, Y Kishimoto, H Kawasaki, C Hirayama
1Department of Internal Medicine, Saiseikai Gotsu General Hospital, Gotsu, Japan, 2Department of Pathobiological Science and Technology, School of Health Science, Tottori University, Yonago, Japan, 3Department of Internal Medicine, San-in Rosai Hospital, Yonago, Japan
519 Switching to a silenced metastatic phenotype by chromosome 18 transfer into the pancreatic cancer cells
LP Lefter, M Sunamura, T Furukawa, K Takeda, S Matsuno, A Horii
1First Department of Surgery, 2Department of Molecular Pathology; Tohoku University, Sendai, Miagy Japan
520 The prognostic relevance of folylpolyglutamate synthetase (FPGS), γ -glutamyl hydrolase (GGH), reduced folate carrier (RFC-1) and thymidylate synthase (TS) gene expression levels in patients with colorectal cancer.
E Odin, Y Wettergren, G Carlsson, L Larsson, BG
University of Gothenburg, Sahlgrenska University Hospital/Ãstra, Gothenburg, Sweden
521 Equilibrium phophorylated/dephosphorilated rb and p21 genes products in pathological human prostates.
M Royuela, MI Arenas, J Alfaro, M Ricote, MVT Lobo, R Vera, B Fraile, R Paniagua
University of Alcala, Alcala de Henares, Madrid Spain
522 The cAMP responsive element a mediator construct between nerves and enteroendocrine cell development
GE Holle, J Dietl, I Demir
Walther Straub Inst.f.Pharmacology&Toxicology;, Germany, Munich, Germany